secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2023-10-30T23:59:59+00:00
Accession:  0001213900-23-081575
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity Therapeutics faces Nasdaq delisting after bid price below $1 for 30 days; cumulative reverse split ratio >250:1
--------------------------------------------------------------------------------

- Received Nasdaq notice Oct 27, 2023: bid price below $1 for 30 consecutive business days.
- Effected 1:35 reverse stock split on Mar 24, 2023 and 1:40 on Jun 28, 2023; cumulative ratio >250:1.
- Not eligible for 180-day compliance period due to prior reverse splits; delisting unless appeal is requested.
- Company intends to appeal; stock continues trading during appeal; delisting effective Nov 7, 2023 if no appeal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023081575/0001213900-23-081575-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023081575/ea187416-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-081575

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer